Day 1

TCT 2014 – Poster Presentation | Inspiron Registry: Safety and efficacy in a group of patients at very high risk.

solaci
solaci
476
0

6_poster_presentation

TCT
2014-09-14

Previous article
TCT 2014.
Next article
Mitra-Clip: a valid alternative for high risk patients
solaci
solaci

More articles by this author

ISAR-CLOSURE: FemoSeal and ExoSeal versus manual compression after femoral access

solaci - 0
Previous studies with vascular closure devices showed shorter hemostasis and less downtime post-procedure. This study compared the safety and efficacy of two vascular closure...

CLEAN-TAVI: transcatheter aortic valve replacement with cerebral protection

solaci - 0
The stroke is a leading complication of post transcatheter aortic valve implantation increasing up to 3 times the mortality of these patients. In the...

PARTNER cohort B: 5-year results of a balloon-expandable valve on inoperable patients

solaci - 0
This study included 358 patients considered inoperable, randomized to TAVR with expandable balloon valve versus conservative treatment. The 5-year end points included all-cause mortality,...

CoreValve US Pivotal Trial: 2-year results of the self-expanding valve on inoperable patients

solaci - 0
This study evaluated the safety and effectiveness of the CoreValve transcatheter valve replacement in patients with severe aortic stenosis with extreme risk for surgery.  The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 1

ISAR-CLOSURE: FemoSeal and ExoSeal versus manual compression after femoral access

Previous studies with vascular closure devices showed shorter hemostasis and less downtime post-procedure. This study compared the safety and efficacy...
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Dr. Omar Tupayachi - 0
Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Dr. Juan Manuel Pérez - 0
Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Dr. Juan Manuel Pérez - 0
Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...